Bioceres Crop Solutions (BIOX) Equity Average (2017 - 2026)

Bioceres Crop Solutions has disclosed Equity Average across 10 years of filings, most recently posting $72.1 million for Q1 2026.

• Equity Average for Q1 2026 came in at $72.1 million, down 76.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.1 million (down 76.68% YoY), and the FY2025 annual result was $308.4 million, down 9.55% from the prior year.
• Equity Average came in at $72.1 million for Q1 2026 at Bioceres Crop Solutions, down from $167.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $332.4 million in Q2 2024 to a low of $72.1 million in Q1 2026.
• The 5-year median for Equity Average is $286.9 million (2025), against an average of $261.8 million.
• Across the five-year window, Equity Average jumped 167.51% in 2022 and plunged 76.68% in 2026, its largest moves.
• Bioceres Crop Solutions' Equity Average stood at $276.6 million in 2022, then increased by 8.39% to $299.8 million in 2023, then advanced by 3.26% to $309.5 million in 2024, then plunged by 45.87% to $167.5 million in 2025, then plunged by 56.99% to $72.1 million in 2026.
• The last three Equity Average figures came in at $72.1 million (Q1 2026), $167.5 million (Q4 2025), and $262.0 million (Q3 2025), per Business Quant data.